Fundamental Analysis
37 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -54.0% | +116.7% | 2 / 3 | -10.3% | -3.47 pp | -3.06 pp | +12.7% | 0.12 | 7.09 | 358 | −10,3% | 11,5 | −54,0% | 7.09 | 8.55 | −17,1% |
| Pts | 0 | 12 | 8 | 0 | 0 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 17.000 (close price on 2026-10-16)EPS (TTM): 2.399
Financial charts
1.Revenue & growth
VND bn358Q3/26
1.Revenue & growth
VND bn358Q3/26
2.Profit & growth
VND bn11,5Q3/26
3.Profit mix (Penman)
VND bn135Q3/26
4.Margins & cost structure
%9.8%Q3/26
5.Returns & cash cycle
% · days12.4%Q3/26
6.Earnings quality & cash
VND bn68,8Q3/26
7.Asset structure
VND bn1.234Q3/26
8.Funding & debt health
VND bn · times1.234Q3/26
9.Revenue backlog
VND bn0,01Q3/26
10.Valuation
times · %7,1×Q3/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %256Q3/26
Adjusted EPS growth, latest quarter
-54.0%
Average adjusted EPS growth, 3 quarters
117%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
Share history could not be reconciled
Source: vnstockData through Q3/26